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Studies in individuals with spinal cord injury (SCI) suggest the vasculature is hyperreactive
to angiotensin II (Ang II). In the present study, the effects of SCI on the reactivity of
the rat tail and mesenteric arteries to Ang II have been investigated. In addition, the
effects of SCI on the facilitatory action of Ang II on nerve-evoked contractions of these
vessels were determined. Isometric contractions of artery segments from T11 (tail artery)
or T4 (mesenteric arteries) spinal cord-transected rats and sham-operated rats were
compared 6–7 weeks postoperatively. In both tail and mesenteric arteries, SCI increased
nerve-evoked contractions. In tail arteries, SCI also greatly increased Ang II-evoked
contractions and the facilitatory effect of Ang II on nerve-evoked contractions. By contrast,
SCI did not detectably change the responses of mesenteric arteries to Ang II. These
findings provide the first direct evidence that SCI increases the reactivity of arterial vessels
to Ang II. In addition, in tail artery, the findings indicate that Ang II may contribute to
modifying their responses following SCI.
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INTRODUCTION
Angiotensin II (Ang II) plays an important role in the regulation
of peripheral resistance. Although acutely interrupting Ang II sig-
naling produces at most a small reduction in blood pressure in
healthy humans, Ang II does contribute to the elevation of blood
pressure that occurs when the activity of the renin-angiotensin
system is increased (Timmermans et al., 1993). Following spinal
cord injury (SCI), when supraspinal regulation of the vascula-
ture below the lesion is lost, the renin-angiotensin system also
plays a greater role in regulating vascular resistance (Popa et al.,
2010). In comparison with able-bodied subjects, individuals with
thoracic or cervical SCI have higher renin levels in their plasma
when supine (Mathias et al., 1980; Kooner et al., 1988; Groothuis
et al., 2010b). Furthermore, in patients with cervical SCI, there
was a rapid and marked rise in plasma renin levels during a
head up tilt (Mathias et al., 1980). This posturally evoked renin
release occurs independently of sympathetic nerve activity and
most likely depends on the fall in renal perfusion pressure causing
stimulation of juxtaglomerular renin secreting cells (see Mathias
et al., 1980).
Ang II mediates its excitatory effects on arterial vessels both by
directly activating the vascular muscle and by augmenting sym-
pathetic nerve-mediated constriction (Nap et al., 2003). There is
indirect evidence that the vasculature of SCI patients is hyper-
reactive to Ang II (Krum et al., 1992; Groothuis et al., 2010b).
Furthermore, treatment with the angiotensin converting enzyme
inhibitor captopril is reported to lower blood pressure during
spinal reflex-evoked hypertensive episodes [so called autonomic
dysreflexia (AD)] that are triggered by bladder or colon disten-
sion or by other unheeded sensory stimuli arising caudal to an
SCI (Esmail et al., 2002). The circulating levels of renin and Ang II
do not change during experimentally induced AD (Mathias et al.,
1981; Groothuis et al., 2010a), indicating the renin-angiotensin
system does not contribute directly to the rise in blood pres-
sure during AD. Therefore, the hypotensive action of captopril
during AD could potentially be explained by a reduction in the
facilitatory effect that basal levels of Ang II have on sympathetic
nerve-mediated vasoconstriction.
This study tested the hypothesis that chronic SCI increases the
reactivity of rat tail and mesenteric arteries to Ang II. These arter-
ies were selected because they are known to be strongly activated
during AD in rats (Laird et al., 2006; Lujan et al., 2010). Captopril
reduces blood pressure in SCI rats (Osborn et al., 1989), demon-
strating that Ang II contributes to the maintenance of blood pres-
sure in this species following spinal injury. Also like in humans,
the blood pressure rise during AD in rats is explained by sympa-
thetic nerve-mediated vasoconstriction (Santajuliana et al., 1995).
Furthermore, evidence indicates that SCI leads to an augmenta-
tion of sympathetic neurovascular transmission that contributes
to generation of AD in both humans and rats (Teasell et al.,
2000; McLachlan and Brock, 2006). Therefore, it is possible that
Ang II contributes to the augmentation of nerve-evoked vasocon-
striction following SCI. In both tail and mesenteric arteries, the
possibilities that SCI increases the reactivity to the vascular mus-
cle to Ang II and/or increases the facilitatory action of this peptide
on sympathetic nerve-evoked constriction were investigated.
MATERIALS AND METHODS
All experimental procedures were approved by the University of
Melbourne Animal Experimentation Ethics Committee and they
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conformed to the Australian Code of Practice for the Care and
Use of Animals for Scientific Purposes.
SPINAL CORD TRANSECTION
The spinal cord was transected in 14 female Sprague-Dawley rats
(∼8 weeks of age) that were anesthetized with isoflurane (2–3%
in oxygen). Eight of these rats had a spinal cord transection at
the T11 spinal segment and were used to study the effects of
SCI on tail arteries. This lesion severs all bulbospinal connec-
tions to the preganglionic neurons that control the tail artery,
which are located in the T13-L2 spinal segments (Rathner and
McAllen, 1998; Smith and Gilbey, 1998). To study the effects of
SCI on mesenteric arteries, the spinal cord was transected at the
T4 spinal segment in six rats. In the rat, the sympathetic pregan-
glionic neurons projecting in the splanchnic nerves are located
in the spinal cord between the T4 and T12 spinal segments and
transection at the T4 spinal segment will remove virtually all
their bulbospinal inputs while damaging <5% of these neurons
directly (Anderson et al., 1989). To lesion the spinal cord, a lon-
gitudinal incision was made through the back skin to expose
the underlying musculature and the T3–4 or T10 vertebrae were
identified. The muscles connecting to the spines of the vertebrae
were detached and the spinal cord was exposed by a laminec-
tomy over the T4 or T11 spinal segment (underlying the T3
and T10 vertebra, respectively; Gelderd and Chopin, 1977). The
spinal cord was cut with fine scissors and the laminectomy site
was closed with three layers of sutures through the adjacent ver-
tebral musculature, the subdermal tissues, and the skin. Sterile
saline (2ml) and analgesic (0.06mg/kg buprenorphine; Reckitt
Benckiser, Sydney, NSW, Australia) were administered postoper-
atively by intraperitoneal injection, and the animal was placed in
a cage on a heated pad to recover from the anesthesia. Additional
injections of saline and analgesic were administered daily for the
first 3 postoperative days. Bladders were manually expressed three
times daily until the animals regained the ability to empty their
own bladders. In 15 age-matched sham-operated controls, the
laminectomy was performed to expose the spinal cord (7 at T4
and 8 at T11) and postoperative treatments were similar except
for bladder management.
The SCI and sham-operated rats were maintained for 6–7
weeks post-surgery. The rats were killed by inhalation of CO2,
with the concentration of CO2 being gradually increased. The
mesentery containing the mesenteric arteries supplying the dis-
tal ∼15 cm of ileum or the tail artery (2–4 cm distal to the base
of the tail) were dissected and maintained in physiological saline
with the following composition (in mM): 150.6 Na+, 4.7 K+,
2 Ca+2 , 1.2 Mg
+
2 , 144.1 Cl
−, 1.3 H2PO−4 , 16.3 HCO
−
3 , and 7.8 glu-
cose. This solution was gassed with 95%O2/5%CO2 and warmed
to 36–37◦C.
MECHANICAL RESPONSES
Segments of tail artery were mounted in wire myographs and
the basal conditions were normalized as described in Al Dera
et al. (2012). The procedure for normalizing the basal conditions
was different for mesenteric arteries. Segments of second-order
mesenteric artery (∼1.5mm in length) were mounted isomet-
rically between stainless steel wires (40μm diameter) in two
four-chamber myographs (Multi Myograph model 610M, Danish
Myo Technology). To normalize the basal conditions, Laplace’s
equation was used to convert the measured force to the effective
transmural pressure (see Mulvany and Halpern, 1977). Initially,
arteries were gradually stretched to establish the inner circum-
ference at an effective transmural pressure of 13.3mN mm−2
(100mm Hg). The lumen circumference was then adjusted to
90% of that determined at 13.3mN mm−2. Using these normal-
ization protocols, both tail arteries and mesenteric arteries were
mounted at the peak of their length-force relation (Mulvany and
Halpern, 1977; Yeoh et al., 2004a). For both tail arteries and
mesenteric arteries the neurally and chemically evoked contrac-
tions were measured as increases in wall tension (force/2 × vessel
length; Mulvany and Halpern, 1977).
After mounting, all vessels were allowed to equilibrate for
at least 30min. During this period the mesenteric arteries were
treated with 1μM capsaicin for 10min to remove the inhibitory
effects of activating the peptidergic primary afferent axons on
nerve-evoked contractions (Haddock and Hill, 2011). Tail arter-
ies are very sparsely innervated by peptidergic primary afferent
axons and their activation does not inhibit nerve-evoked con-
tractions (Li and Duckles, 1993). All vessels were then stimulated
with three applications of phenylephrine (3μM for tail arteries
and 10μM for mesenteric arteries) to confirm that the tissues
were viable. The contractions to the first and second applica-
tions of phenylephrine were terminated by washout and when the
third contraction had plateaued, carbachol (1μM) was applied to
confirm that the endothelium was intact.
Ang II-INDUCED CONTRACTIONS
For both mesenteric and tail arteries, non-cumulative
concentration-response curves for Ang II (1–100 nM) were
constructed by increasing the concentration applied by log
increments. The tissues were exposed to each concentration of
Ang II for 3–4min, with the tissues washed immediately after
the contractions had peaked. A 35–40min washout period was
left between applications of Ang II to minimize the effects of
desensitization of Ang II receptor function.
ELECTRICALLY EVOKED CONTRACTIONS
Electrical stimuli (0.2ms pulse width, 20V for tail arteries and
15V for mesenteric arteries) supplied by a four channel stimu-
lator (EXP-ST-CH4, Experimetria, Balatonfüred, Hungary) were
applied through platinum plate electrodes mounted either side of
the tissue. It was confirmed that these stimuli produced supra-
maximal responses that were abolished by 0.5μM tetrodotoxin,
indicating that they were due entirely to the action of neurotrans-
mitter released from the perivascular nerves. Initially a stimulus
frequency-contraction curve was constructed for each tissue with
the tail arteries being stimulated with trains of 25 stimuli at 0.1–
1Hz whereas the mesenteric arteries were stimulated with trains
of 100 stimuli at 1, 3, 5, 10, and 20Hz. Each of these trains of
stimuli was separated by a 4min interval. These different stimulus
parameters were used because tail arteries were more responsive
to electrical stimulation of their perivascular nerves than mesen-
teric arteries, which were only weakly activated by trains of stimuli
at 1Hz (cf. Figures 1A,C).
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FIGURE 1 | Spinal cord injury (SCI) increased nerve-evoked
contractions of both tail and mesenteric arteries. (A) Representative
traces showing contractions of a tail artery segment from a sham-operated
(black trace) and a SCI (red trace) rat evoked by 25 stimuli at 0.1, 0.3, 0.5,
and 1Hz. (B) Peak increases in wall tension produced by these trains of
stimuli in tail arteries from sham-operated (white bars, n = 8) and SCI (red
bars, n = 8) rats. (C) Representative traces showing contractions of a
mesenteric artery segment from a sham-operated (black trace) and a SCI
(red trace) rat evoked by 100 stimuli at 1, 3, 5, 10, and 20Hz. (D) Peak
increases in wall tension produced by these trains of stimuli in mesenteric
arteries from sham-operated (white bars, n = 7) and SCI (red bars, n = 6)
rats. In (B,D), the data are presented as a mean and SE with statistical
differences between control and SCI arteries indicated by asterisks
(unequal variance t-test; ∗P < 0.05, ∗∗P < 0.01).
In tail arteries, the effects of Ang II (1–100 nM; Auspep,
Tullamarine, VIC, Australia) on nerve-evoked contractions were
investigated by assessing effects on contractions to trains of 5
stimuli at 0.5Hz delivered at 4min intervals. In mesenteric artery,
the effects of Ang II were assessed on contractions to trains of 20
stimuli at 10Hz delivered at 4min intervals. Because of the poten-
tial for desensitization of Ang II receptor function, each tissue was
only exposed to a single concentration of Ang II for ∼16min.
The effects of losartan (selective AT1antagonist; Sigma-Aldrich,
Castle Hill, NSW, Australia) on Ang II-induced facilitation of
nerve-evoked contractions were assessed in tissues that had not
previously been exposed to Ang II.
DATA ANALYSIS
The output from the myograph was recorded and analyzed using
a PowerLab data acquisition system and the program Chart
(ADInstruments, Bella Vista, NSW, Australia). The peak ampli-
tudes of contractions to the trains of electrical stimuli and to
phenylephrine and Ang II were measured. Relaxation responses
to carbachol were expressed as a percentage reduction of the con-
striction to phenylephrine measured at the time carbachol was
applied.
All statistical comparisons were made using SPSS 22 (IBM
corporation, NY, USA). Before comparison, the data sets were
checked for normality using Kolmogorov–Smirnov tests. Where
data set were normally distributed, the data are presented as
means ± standard error of the mean (SE) and comparisons were
made with unequal variance t-tests (Ruxton, 2006). Where the
data sets were not normally distributed, the data are presented
as median and interquartile range and comparisons were made
with Mann–Whitney U-tests. When multiple pairwise compar-
isons were made between data obtain in the same tissues, the
P-values were adjusted using the false discovery rate procedure
(Curran-Everett, 2000). P-values < 0.05 were considered to indi-
cate significant differences. In all cases, n indicates the number of
animals studied.
RESULTS
BASAL CONDITIONS AND RESPONSES TO PHENYLEPHRINE AND
CARBACHOL
After the normalization procedure the lumen diameter of tail
arteries andmesenteric arteries from SCI rats did not differ signif-
icantly from those of sham-operated rats (Table 1). However, the
basal wall tension after equilibration was slightly smaller (∼15%)
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Table 1 | Basal lumen diameter and wall tension and the responses to phenylephrine (PE) and carbachol in tail and mesenteric arteries from
sham-operated and SCI rats.
Tail artery
Diameter (µm) Basal wall tension (mN mm−1) 3µM PE (mN mm−1) 1µM Carbachol % Relaxation
Sham (n = 8) 798 ± 26 4.5 ± 0.07 8.7 ± 0.9 62 ± 4
SCI (n = 8) 772 ± 25 3.9 ± 0.21 9.3 ± 1.1 51 ± 6
P 0.50 <0.05* 0.52 0.18
Mesenteric artery
Diameter (µm) Basal wall tension (mN mm−1) 10µM PE (mN mm−1) 1µM Carbachol % Relaxation
Sham (n = 7) 296 ± 10 1.3 ± 0.1 4.5 ± 0.2 70 ± 10
SCI (n = 6) 290 ± 10 1.3 ± 0.1 4.5 ± 0.2 76 ± 5
P 0.87 0.97 0.87 0.64
Data are present as mean ± SE and comparisons between arteries from sham-operated and SCI rats were made with unequal variance t-tests. * indicates significant
differences.
for the tail arteries from SCI rats (Table 1). The basal wall ten-
sion did not differ between mesenteric arteries from SCI and
sham-operated rats (Table 1).
For both tail arteries and mesenteric arteries, the peak increase
in wall tension produced by phenylephrine (3μM for tail artery
and 10μM for mesenteric artery) did not differ between vessels
from SCI and sham-operated rats (Table 1). The % relaxation
produced by carbachol of phenylephrine constricted tail arteries
and mesenteric arteries also did not differ between vessels from
SCI and sham-operated rats (Table 1).
SCI INCREASED NERVE-EVOKED CONTRACTIONS
As previously reported (Yeoh et al., 2004a; Brock et al., 2006;
Al Dera et al., 2012), in both tail and mesenteric arteries
SCI increased the size of nerve-evoked contractions (Figure 1).
However, the magnitude of this effect was greater in tail arter-
ies than in mesenteric arteries, with contractions to trains of
stimuli at 1Hz being increase by ∼2-fold in mesenteric arteries
and ∼3-fold in tail arteries.
SCI INCREASED THE REACTIVITY OF TAIL ARTERIES TO Ang II
Figure 2 shows concentration-contraction curves for Ang II (1–
100 nM) in tail arteries (Figure 2A) and mesenteric arteries
(Figure 2B) from sham-operated and SCI rats. In tail arteries
from SCI rats (n = 8), the responses to Ang II were more variable
but they were significant larger than those from sham-operated
rats (n = 8; Figure 2A). In mesenteric arteries from both control
and SCI rats, the contractions to Ang II at 10 and 100 nM were
small and variable but there was a tendancy for the Ang II-evoked
contractions of mesenteric arteries from SCI rats (n = 6) to be
larger than those from sham-operated rats (n = 7; Figure 2B).
This difference did to reach the level of statistical significance
(Figure 2B). However, because of the considerable variability of
the responses to Ang II, a larger number of control and SCI arter-
ies would need to be tested to exclude the possibilty that SCI
increases the sensitivity of mesenteric arteries to Ang II.
Ang II INCREASED NERVE-EVOKED CONTRACTIONS
In tail arteries (Figure 3A) and mesenteric arteries (Figure 3B),
the contraction to Ang II peaked within 4min of application and
then rapidly declined. In contrast, the facilitatory effect of Ang II
on nerve-evoked contractions peaked within 4–8min of applica-
tion and then slowly declined in some tissues. For this reason the
effects of Ang II on nerve-evoked contractions were measured at
the second response in its presence (∼7min after adding Ang II).
At 1 nM, Ang II increased nerve-evoked contractions of tail
arteries from SCI rats and this facilitatory action of Ang II did not
increase when 10 or 100 nMwas applied (Figure 3C). By contrast,
in tail arteries from sham-operated rats, the facilitatory action
of Ang II on nerve-evoked contractions increased with the con-
centration applied (1–100 nM), with 1 nM having little effect on
these responses (Figure 3C). Ang II also increased the amplitude
of nerve-evoked contractions of mesenteric arteries (Figure 3B),
but at 1–100 nM the increment in wall tension produced by this
agent did not differ between the vessels from sham-operated and
SCI rats (Figure 3D).
THE FACILITATORY EFFECT OF Ang II ON NERVE-EVOKED
CONTRACTIONS WAS REDUCED BY LOSARTAN
The effects of the Ang II type 1 (AT1) receptor antagonist
losartan on responses to Ang II were investigated. In tail arter-
ies and mesenteric arteries from both sham-operated and SCI
rats, 100 nM losartan abolished contractions to 100 nM Ang II
(Figures 4A,B). At this concentration, losartan on its own had
no effect on nerve-evoked contractions of either artery type
(Figures 4C,D). In tail arteries from both groups of rats, 100 nM
losartan abolished the augmentation of nerve-evoked contrac-
tions produced by 100 nM Ang II (Figure 4E). Similarly, in
mesenteric arteries from both groups of rats, the facilitatory
action of 1 nM Ang II on nerve-evoked contraction was greatly
reduced by this concentration of losartan (Figure 4F).
DISCUSSION
The main finding of this study is that chronic SCI has differential
effects on the reactivity of tail and mesenteric arteries to Ang II.
In tail arteries, but not mesenteric arteries, SCI produced a large
increase in reactivity of the vascular muscle to Ang II and also
markedly increased the facilitation of nerve-evoked contractions
produced by Ang II. Therefore, the hypothesis that SCI produces
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FIGURE 2 | Spinal cord injury (SCI) increased the responsiveness of
tail arteries to angiotensin II (Ang II). (A,B) Concentration–contraction
curves for Ang II (1–100 nM) in tail arteries (A) and mesenteric arteries
(B) from sham-operated (open circles; tail artery n = 8, mesenteric
artery n = 7) and SCI rats (solid red circles; tail artery n = 8,
mesenteric artery n = 6). In (A), the data are presented as mean and
SE and statistical comparisons between the summed data for
sham-operated and SCI arteries was made with a unequal variance
t-test (P indicated in A). In (B), the data are present as median and
interquartile range and statistical comparison between the summed data
for sham-operated and SCI arteries groups was made with an
Mann–Whitney U-test (P indicated in B).
hyperreactivity of the vaculature to Ang II is supported but the
changes detected depend on the vessel studied.
The increase in nerve-evoked contraction produced by SCI
is almost certainly explained by the decrease in ongoing sym-
pathetic nerve activity caudal to the lesion (Maiorov et al.,
1997; Yeoh et al., 2004b). Short-term abolition of sympathetic
neuroeffector transmission in smooth muscles by decentraliza-
tion (by lesioning the preganglionic inputs to their supplying
postganglionic neurons) or by denervation increases their sensi-
tivity to α-adrenoceptor agonists (Fleming and Westfall, 1988).
Accordingly, decentralization, denervation and SCI produced a
transient increase in sensitivity of tail artery vascular muscle to
α1-adrenoceptor agonists within 1–2 weeks of surgery but this
had subsided by 6–8 weeks (Yeoh et al., 2004a,b; Tripovic et al.,
2010). While denervated tail arteries did not have maintained
hyperreactivity to α1-adrenoceptor agonists, these vessels had a
marked and maintained increase in their reactivity to Ang II
(Tripovic et al., 2010). A similar increase in reactivity to Ang II
has been demonstrated in decentralized tail arteries 2 weeks post-
operatively (Tripovic et al., 2010) and here SCI for 6–7 weeks
increased reactivity to Ang II. Therefore, in tail artery, chronic
interruption of sympathetic neuroeffector transmission increases
the reactivity of the vascular muscle to Ang II.
The long-term effects of surgically induced denervation on the
reactivity of mesenteric arteries have not been reported. However,
it has been reported that SCI for 7 weeks does not increase
sensitivity of the vascular muscle in mesenteric arteries to α1-
adrenoceptor agonists (Brock et al., 2006). In the present study,
the highest concentration of Ang II tested (100 nM) produced
a small contraction of mesenteric arteries from sham-operated
rats (∼5% of the contraction to 10μM phenylephrine). In SCI
mesenteric arteries, there was a tendency for the contractions to
100 nM Ang II to be larger (∼15% of the contraction to 10μM
phenylephrine). However, the relatively large variability of the
contractions to Ang II observed in mesenteric arteries means that
a larger number of vessels would need to be studied to estab-
lish whether or not SCI increases vascular muscle reactivity to
this peptide. Irrespective of the effects of SCI on Ang II-evoked
contractions of mesenteric arteries, the facilitatory effect of this
agent on nerve-evoked contractions of these vessels was not
significantly changed by SCI.
The present study did not investigate the mechanisms under-
lying the facilitation of nerve-evoked contractions produced by
Ang II. In both tail and mesenteric arteries, Ang II has been
demonstrated to increase noradrenaline release from the perivas-
cular nerve terminals but themaximally effective concentration in
tail arteries (∼1μM; Cox et al., 1996b) is about 100-fold greater
than that in mesenteric arteries (∼10 nM; Morato et al., 2006).
In mesenteric arteries, 10 nM Ang II increased nerve-evoked
contractions of mesenteric arteries but did not increase contrac-
tions to exogenously applied noradrenaline (Balt et al., 2001).
Therefore, in mesenteric arteries, the facilitatory effect of Ang
II on nerve-evoked contractions appears to be explained by an
increase in neurotransmitter release from the sympathetic nerve
terminals. As the facilitatory effect of Ang II on nerve-evoked con-
tractions did not differ between mesenteric arteries from SCI and
sham-operated rats, we assume that the facilitatory effect of Ang
II on noradrenaline release is not changed by SCI.
In tail arteries, Ang II at 100 nM (the highest concentra-
tion used in the present study) increased contractions to both
nerve stimulation and exogenously applied noradrenaline but
did not increase noradrenaline release (Thorin and Atkinson,
1994). Thus, in arteries from sham-operated rats, the augmen-
tation of nerve-evoked contractions produced by Ang II is most
likely due to a postjunctional action of this peptide. As SCI
markedly increased contractions of tail arteries produced by Ang
II, a postjunctional increase in smooth muscle reactivity is likely
to contribute the augmented facilitatory effect of this peptide
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FIGURE 3 | Angiotensin II (Ang II) increased nerve-evoked contractions
of both tail arteries and mesenteric arteries. In tail arteries, but not
mesenteric arteries, the increment in the size of nerve-evoked contractions
produced by Ang II was markedly increased by spinal cord injury (SCI). (A)
Representative traces showing contractions of tail artery segments from a
sham-operated (left panel) and a SCI (right panel) rat evoked by 5 stimuli at
0.5Hz before and during application of 1, 10, and 100 nM Ang II. (B)
Representative traces showing contractions of mesenteric artery segments
from a sham-operated (left panel) and a SCI (right panel) rat evoked by 20
stimuli at 10Hz before and during application of 1, 10, and 100 nM Ang II.
(C,D) The increment in the size of nerve-evoked contractions produced by
Ang II (1–100 nM) in tail arteries (C) and mesenteric arteries (D) from
sham-operated (open circles; tail artery n = 8, mesenteric artery n = 7) and
SCI (solid red circles; tail artery n = 8, mesenteric artery n = 6) rats. The
“zero” Ang II data is for time-matched controls with no Ang II added. In (C,D),
the data are present as mean and SE and statistical comparisons between
the curves were made by comparing the summed data for sham-operated
and SCI arteries using unequal variance t-tests (P indicated in C,D).
on nerve-evoked contractions. However, the possibility that SCI
increases the sensitivity of the sympathetic nerve terminals to
Ang II in tail artery cannot be excluded. As previously reported
(Cox et al., 1996a; Balt et al., 2001), the AT1 receptor antagonist
losartan blocked both Ang II-induced contractions and the aug-
mentation of nerve-evoked contractions produced by this peptide
in both tail and mesenteric arteries. As AT1 receptors mediate
both the prejunctional and postjunctional actions of Ang II in
these arteries (Cox et al., 1995; Ziogas and Vessey, 2001), these
findings do not resolve the site at which Ang II acts to increase
nerve-evoked contractions.
Groothuis et al. (2010b) have provided evidence that suggests
arterial reactivity to Ang II is increased in the legs of patients with
an SCI in the middle to lower thoracic region (T4–T12) of the
spinal cord. When supine these SCI subjects had a higher arte-
rial vascular resistance in the legs than did able-bodied controls.
By contrast, in the forearms where neural control the vasculature
is unaffected by the SCI, arterial vascular resistance did not dif-
fer between the SCI and control groups. Under these conditions,
the AT1 receptor antagonist irbesartan reduced arterial vascular
resistance in the legs of SCI subjects but not in those of control
subjects. Irbesartan had no effects on arterial vascular resistance
in the forearms of both groups. As it would be predicted that the
vasculature in the arms and legs is exposed to the same circulating
concentration of Ang II, these findings suggest the vasculature in
the legs of the SCI subjects is hyperreactive to Ang II. In accord
with this suggestion, the dose of intravenously infused Ang II
required to raise blood pressure by 20mmHg was reduced in
quadriplegic SCI patients (Krum et al., 1992).
The concentrations of Ang II that constrict animal and human
arterial vessels in vitro are typically much higher than those in
blood (Camarda et al., 2002). In humans, the normal levels of
Ang II in plasma are in the range 1–10 pM (Hermann et al., 1988)
and in rats is ∼15 pM (Hermann et al., 1988). In the study of
Groothuis et al. (2010b), patients with middle to lower thoracic
SCI had slightly but significantly higher levels of circulating Ang
II (∼5 pM) than did able bodied subjects (∼3 pM). The low level
of Ang II in blood raises the question as to the concentration that
is present in the vascular wall. Ang II can be generated locally
in vascular wall by conversion of angiotensin I (Ang I) to Ang II
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FIGURE 4 | The angiotensin II (Ang II) type 1 receptor antagonist losartan
(100nM) blocked both Ang II-evoked contractions and the enhancement
of nerve-evoked contractions produced by Ang II in tail arteries and
mesenteric arteries from sham-operated and spinal cord injured (SCI)
rats. On its own losartan did not change nerve-evoked contractions. (A,B)
Peak increases in wall tension produced by 100 nM Ang II in tail arteries (A;
sham-operated n = 8, SCI n = 8) or mesenteric arteries (B; sham-operated
n = 7, SCI n = 6) in the absence (white bars) or in the presence (red bar ) of
losartan. (C,D) Peak increases in wall tension evoked by nerve stimulation
(tail artery: 5 stimuli at 0.5Hz; mesenteric artery: 20 stimuli at 10Hz) before
(white bar ) and during (red bar ) application of losartan in tail arteries (C;
sham-operated n = 6, SCI n = 6) and mesenteric arteries (D; sham-operated
n = 7, SCI n = 6). (E) The increment in the size of nerve-evoked contractions
produced by 100 nM Ang II in tail arteries in the absence (white bars;
sham-operated n = 7, SCI n = 7) or in the presence (red bars; sham-operated
n = 7, SCI n = 7) of losartan. (F) The increment in the size of nerve-evoked
contrations produced by 1 nM Ang II in mesenteric arteries (sham-operated
n = 7, SCI n = 6) in the absence (white bars) or in the presence (red bars) of
losartan. Data are presented as median and interquartile in (A,B) and mean
and SE in (C–F). Statistical differences between responses in the absence
and in the presence of losartan are indicated by asterisks (by Mann–Whitney
U-tests (in A,B) or unequal variance t-tests (in E,F); ∗P < 0.05, ∗∗P < 0.01).
(Schuijt et al., 2002). This has been demonstrated in both rat tail
and mesenteric arteries (Collis and Keddie, 1981; Ziogas et al.,
1984). The circulating levels of Ang I are higher than those of
Ang II (∼20 pM in humans and ∼70 pM in rats; Hermann et al.,
1988) and it has been estimated that the concentration of Ang
II generated from Ang I in the interstitial fluid within the vascu-
lar wall may be up to 10-fold higher than the circulating level of
Ang I (Schuijt et al., 2002). In addition, some blood vessels have
been demonstrated to synthesize angiotensinogen that is con-
verted locally, by renin taken up from the circulation, to Ang I that
is then converted to Ang II (Bader et al., 2001). For these reasons
it is possible that the concentration of Ang II present in the vascu-
lar wall is much higher than the circulating level. It is also possible
that the increased contribution of Ang II tomaintenance of vascu-
lar resistance in legs of SCI subjects is explained by increased local
synthesis of Ang II, rather than an increase in vascular reactivity
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to this peptide (Groothuis et al., 2010b). In the present study,
the SCI-induced enhancement of nerve-evoked contractions can-
not be attributed to endogenously synthesized Ang II as it was
not reduced by the AT1-receptor receptor antagonist losartan
(Figures 4C,D).
SIGNIFICANCE FOR CARDIOVASCULAR CONSEQUENCES OF SCI
This is the first study to directly demonstrate that SCI increases
the reactivity of arterial vessels to Ang II. This change potentially
contributes to restoration of blood pressure control following
SCI in both human and rats. In both humans and rats, the
splanchnic vascular bed is believed to play a dominant role in
the rise in blood pressure during AD (Mathias and Frankel, 1999;
Lujan et al., 2010). The present study demonstrates that Ang II
amplifies nerve-evoked constrictions of mesenteric arteries but
that the magnitude of this effect was not changed by SCI. So
while blockade of Ang II actions will potentially reduce nerve-
evoked vasoconstriction of arterial vessels in splanchnic vascular
bed, it would not be expected to reduce the SCI-induced hyper-
reactivity of these vessels to neural activation. However, while
captopril has been reported to be effective in reducing blood pres-
sure during AD in SCI patients (Esmail et al., 2002), at present
it is unknown whether this treatment is effective during AD
in rats.
The tail artery controls the blood flow to tail skin, which is
reduced during AD evoked by colorectal distension in SCI rats
(Laird et al., 2006). Neural regulation of skin blood flow can
potentially contribute to the regulation of peripheral resistance
(see Rowell, 1984). In humans, during AD there is widespread
cutaneous vasoconstriction with cold skin being a characteristic
feature of this condition (Mathias and Frankel, 1999). Therefore,
concurrent activation of arterial vessels supplying skin, muscle,
and visceral organs almost certainly contributes to the overall
increase in peripheral resistance during AD. Thus, it is possible
that the blood pressure lowering effect of captopril during AD
is due, in part, to a reduction in hyperreactivity of cutaneous
arterial vessels to neural activation. It is also possible that the
influence of Ang II on neural activation of arterial vessels supply-
ing other vascular beds (e.g., skeletal muscle, kidney) is increased
by SCI.
SCI-induced changes in the neural regulation of skin blood
flow are believed to contribute to both the etiology of pressure
sores and the slowing of skin wound repair in SCI patients (Teasell
et al., 2000). In patients with SCI, it is possible that hyperreactiv-
ity of the cutaneous vasculature to Ang II contributes to both the
reduction in ischemia-induced vasodilation that occurs follow-
ing removal of a pressure stimulus applied to skin (Schubert and
Fagrell, 1991) and to impairing axon reflex-evoked vasodilation
in skin (Kuesgen et al., 2002). Both of these changes contribute to
impairing skin function in SCI patients (Teasell et al., 2000).
In summary, SCI changes the reactivity of the tail artery to
Ang II. This effect may contribute to modifying the contribution
of Ang II to vascular control following SCI. In addition, as the
tail artery supplies blood to tail skin, it is possible that increased
reactivity of cutaneous arterial vessels to Ang II contributes to
impairing skin function following SCI. These possibilities require
further investgation.
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